A Comparative Study Between Laryseal Pro Extraglottic Device and Ambu Aura Gain Laryngeal Mask as a Conduit for Fiberoptic Tracheal Intubation in Pediatric Population
Recruiting
N/A
Interventional Study
Laryseal Pro and Ambu Aura Gain as Conduits for Fiberoptic Endotracheal Intubation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 4 – 8
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 100 (estimated)
- Sponsor
- Cairo University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to compare between Laryseal Pro and Ambu Aura Gain extraglottic devices as conduits for fiberoptic endotracheal intubation regarding time of endotracheal intubation in pediatric population.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age starting from 4 years to 8 years.
* Both genders.
* ASA physical status class I-ll.
* Apparently anatomically normal with normal percentile growth chart, not suspected to have difficult airway.
* Scheduled for day case surgeries more than one hour under general anesthesia.…
Contacts